Novartis AG

Stocks

Market Closed - Swiss Exchange 11:30:36 2026-10-02 EDT			5-day change	1st Jan Change
116.34 ^CHF	-1.46%		-2.89%	+6.15%

10-02	Healthcare Stocks Fall Slightly -- Healthcare Roundup	DJ
10-02	Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion	DJ

Published on 10/30/2025 at 01:35 pm EDT - Modified on 11/07/2025 at 11:47 am EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning and good afternoon, and welcome to the Novartis Immunology Portfolio Update Conference Call and Live Webcast. [Operator Instructions]

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

10-02	Healthcare Stocks Fall Slightly -- Healthcare Roundup	DJ
10-02	Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion	DJ
10-02	Global markets live: RTX, Microsoft, Amazon, Nike, Boeing…
10-02	Novartis to License Drug From China's Abogen in Up to $7.8 Billion Deal -- Update	DJ
10-02	Novartis strikes up to $7.8 billion mRNA deal with China's Abogen	RE
10-02	Novartis to License Drug From China's Abogen in Up to $7.8 Billion Deal	DJ
10-02	Major drugmakers turn to China for licensing deals	RE
10-02	Novartis, Abogen Sign RNA Licensing Agreement Worth up to $7.2 Billion	MT
10-02	Novartis, Abogen Sign RNA Therapeutics Deal With $575 Million Upfront, Up to $7.2 Billion in Milestones	MT
10-02	Novartis strikes up to $7.8 billion mRNA deal with China's Abogen	RE
10-01	Novartis AG : Receives a Sell rating from Goldman Sachs	ZD
10-01	Deals of the day-Mergers and acquisitions	RE
09-30	Merck's experimental skin disease drug succeeds in mid-stage study	RE
09-30	Major drugmakers turn to China for licensing deals	RE
09-29	Pharma sector doubles down on AI to slash costs, timelines	RE